- Condition Overview:
- Stellate nonhereditary idiopathic foveomacular retinoschisis (SNIFR) is a diagnosis characterized by schisis (splitting) primarily of the outer retina, typically in the outer plexiform layer, with lesser involvement of the outer nuclear layer.
- SNIFR is nonhereditary, with no known genetic associations, distinguishing it from conditions like congenital juvenile X-linked retinoschisis (CXLR).
- Typically presents with a stellate pattern of radial spokelike striae in the fovea, though this may not always be visible (e.g., if concurrent conditions like neovascular age-related macular degeneration are present).
- Clinical Presentation:
- Patients are often asymptomatic or have minimal symptoms, with excellent visual acuity (e.g., 20/20).
- Common findings include cystlike changes on optical coherence tomography (OCT) in the foveal and parafoveal regions, primarily in the outer retina, and sometimes in the inner retina (temporal macula).
- No association with optic disc pit, myopic retinoschisis, retinitis pigmentosa, glaucoma, vitreomacular traction, or degenerative retinoschisis in SNIFR.
- Negative family history and no consanguinity are typical, ruling out hereditary causes.
- Diagnostic Evaluation:
- Order an electroretinogram (ERG) as the most appropriate next step to rule out congenital juvenile X-linked retinoschisis (CXLR), which typically shows an electronegative ERG (though it can be normal in some cases).
- CXLR is caused by variations in the RS1 gene and is most common in males, but females may rarely be affected due to lyonization or homozygosity.
- Absence of peripheral white flecks on fundus examination and negative family history make CXLR less likely.
- OCT imaging is critical, showing schisis of the outer plexiform layer in the foveal/parafoveal regions and sometimes inner retina involvement.
- Rule out other causes of foveomacular retinoschisis (e.g., optic pit maculopathy, enhanced S-cone syndrome, medication-induced retinoschisis from niacin or taxanes).
- Differential Diagnosis:
- Key differentials include CXLR, optic pit maculopathy, myopic retinoschisis, retinitis pigmentosa, glaucoma, vitreomacular traction, degenerative retinoschisis, and enhanced S-cone syndrome.
- Enhanced S-cone syndrome is unlikely with good lifelong vision and unremarkable fundus/ERG.
- SNIFR lacks systemic or hereditary associations, unlike other conditions.
- Management:
- Observation is the mainstay for SNIFR due to good visual prognosis and lack of proven benefit from invasive treatments.
- Pars plana vitrectomy and antivascular endothelial growth factor (anti-VEGF) therapy are not indicated for SNIFR, as they do not improve outcomes.
- Topical prednisolone or ketorolac are inappropriate, as the cystic areas are due to retinoschisis, not cystoid macular edema.
- Dorzolamide therapy may be considered if vision deteriorates, with reports of complete resolution of SNIFR and improved vision in some cases.
- Follow-Up:
- No clear guidelines on follow-up frequency, but biannual follow-up is reasonable for asymptomatic patients with stable 20/20 vision.
- Closer monitoring is warranted if the patient becomes symptomatic or shows progression on OCT imaging.
- Epidemiology and Literature:
- SNIFR is often unilateral, but bilateral cases have been reported.
- Most patients in case series are asymptomatic or minimally symptomatic, with splitting most common in the outer plexiform layer.
- Patient Outcome:
- Follow-up every 6 months is appropriate for stable cases.
- Monitor for visual acuity loss or OCT progression, which may necessitate more frequent follow-up or consideration of dorzolamide.
These points emphasize diagnosis, ERG use, differentials, and management, which are critical for OKAP and board exams due to their focus on distinguishing SNIFR from hereditary or acquired retinoschisis and avoiding inappropriate treatments.
- Stellate nonhereditary idiopathic foveomacular retinoschisis (SNIFR) is defined as foveal elevation without alternative explanation for retinoschisis, characterized by abnormal splitting of the retina’s neurosensory layers, primarily in the outer plexiform layer, forming concentric cysts.
- SNIFR is nonhereditary, with no known genetic basis, distinguishing it from X-linked juvenile retinoschisis (CXLR), which involves the RS1 gene and affects photoreceptors and bipolar cells.
- Clinical Presentation:
- Often asymptomatic, with preserved visual acuity (e.g., 20/20), as seen in the 53-year-old female ophthalmologist who was diagnosed incidentally during an equipment checkup.
- Unilateral in this case, though SNIFR can be bilateral in others.
- Fundus examination may show a stellate pattern of cysts, but clinical findings can be subtle, often requiring imaging for detection.
- No systemic diseases, medication use (e.g., niacin, taxanes), or ocular history (e.g., myopia, glaucoma, optic pit) associated in SNIFR.
- Diagnostic Evaluation:
- Multimodal imaging is critical for diagnosis:
- Spectral-domain optical coherence tomography (SD-OCT): Reveals schisis in the outer plexiform layer, with additional involvement of the inner nuclear layer and ganglion cell layer in some cases. The retinal pigment epithelium-ellipsoidal complex is typically preserved, explaining good visual acuity.
- Optical coherence tomography angiography (OCT-A): Noninvasive, shows minimal changes in vascular and perfusion density, no bridging vessels, and a preserved foveal avascular zone (area 0.36 mm², perimeter 2.37 mm in this case). Superficial capillary plexus is highly distributed.
- Fluorescein angiography (FA): Demonstrates almost unaltered foveal changes, with minimal abnormalities, making it less sensitive for SNIFR compared to OCT-based imaging.
- Multifocal electroretinography (mfERG): Detects subtle reduction in dark-adapted a-wave and b-wave amplitudes (e.g., central ring P1 amplitude 30.3 nV/deg in affected eye vs. 66.6 nV/deg in unaffected eye), indicating dysfunction in the Henle fiber layer and Müller fibers. No alteration in b-to-a ratio, unlike CXLR.
- mfERG is key for differentiating SNIFR from other retinopathies (e.g., retinitis pigmentosa, cone dystrophy) but shows nonpathologic responses in the unaffected eye.
- Diagnosis often incidental due to lack of symptoms and subtle clinical findings.
- Differential Diagnosis:
- Key differentials include:
- X-linked juvenile retinoschisis (CXLR): Early onset, bilateral, males, RS1 gene mutation, electronegative ERG, moderate vision loss.
- Myopic foveoschisis: Associated with high myopia and posterior staphyloma (seen in 34% of such cases per Takano and Kishi).
- Optic pit traction, glaucoma, or vitreomacular traction-related retinoschisis.
- SNIFR lacks systemic, hereditary, or structural causes (e.g., no myopia, optic pit, or traction).
- Management:
10:
- Observation is the primary approach due to preserved visual acuity and typically nonprogressive nature.
- No role for invasive treatments like vitrectomy or anti-VEGF therapy, as they do not benefit SNIFR.
- Dorzolamide may be considered if vision deteriorates, with some reports of resolution.
- Follow-Up:
- Routine monitoring with OCT-A and SD-OCT recommended to assess for progression, though SNIFR is often static or slowly progressive.
- No standardized follow-up interval, but biannual checks reasonable for asymptomatic patients with stable vision.
- Epidemiology and Prognosis:
- SNIFR is rare, more commonly unilateral, though bilateral cases exist.
- Visual acuity is relatively preserved due to sparing of the retinal pigment epithelium and ellipsoid zone, as seen in large series (Ober et al.).
- May coexist with exudative maculopathies (e.g., neovascular AMD), complicating the stellate appearance.
- Importance of Imaging:
- OCT-A revolutionizes diagnosis by providing noninvasive vascular data, aiding in detecting subtle changes not visible on FA or clinical exam.
- High-resolution imaging (SD-OCT, OCT-A) surpasses FA and ERG for precision, as FA and ERG are invasive and less practical for screening.
- Routine ophthalmic exams can uncover SNIFR in asymptomatic patients, emphasizing the value of specialized checkups.
- Research Gaps:
- Limited data on SNIFR due to rarity; this case is among the first to use OCT-A and mfERG comprehensively.
- Future studies needed to determine if OCT-A findings (e.g., stable vascular density) are consistent across SNIFR cases or case-specific.
These points emphasize multimodal imaging (OCT-A, SD-OCT, mfERG), differential diagnosis (CXLR, myopic foveoschisis), and management (observation), which are critical for OKAP and board exams due to the need to identify SNIFR’s subtle presentation and avoid unnecessary interventions.